These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
925 related articles for article (PubMed ID: 16841959)
1. Cytochrome P450-mediated metabolism of haloperidol and reduced haloperidol to pyridinium metabolites. Avent KM; DeVoss JJ; Gillam EM Chem Res Toxicol; 2006 Jul; 19(7):914-20. PubMed ID: 16841959 [TBL] [Abstract][Full Text] [Related]
2. Studies on the conversion of haloperidol and its tetrahydropyridine dehydration product to potentially neurotoxic pyridinium metabolites by human liver microsomes. Usuki E; Pearce R; Parkinson A; Castagnol N Chem Res Toxicol; 1996 Jun; 9(4):800-6. PubMed ID: 8831826 [TBL] [Abstract][Full Text] [Related]
3. In vitro characterization of the metabolism of haloperidol using recombinant cytochrome p450 enzymes and human liver microsomes. Fang J; McKay G; Song J; Remillrd A; Li X; Midha K Drug Metab Dispos; 2001 Dec; 29(12):1638-43. PubMed ID: 11717183 [TBL] [Abstract][Full Text] [Related]
4. Enzyme-catalyzed bioactivation of cyclic tertiary amines to form potential neurotoxins. Castagnoli N; Castagnoli KP; Van der Schyf CJ; Usuki E; Igarashi K; Steyn SJ; Riker RR Pol J Pharmacol; 1999; 51(1):31-8. PubMed ID: 10389142 [TBL] [Abstract][Full Text] [Related]
5. Identification of the human liver microsomal cytochrome P450s involved in the metabolism of N-nitrosodi-n-propylamine. Teiber JF; Hollenberg PF Carcinogenesis; 2000 Aug; 21(8):1559-66. PubMed ID: 10910959 [TBL] [Abstract][Full Text] [Related]
6. Cytochrome P450 2E1 is the principal catalyst of human oxidative halothane metabolism in vitro. Spracklin DK; Hankins DC; Fisher JM; Thummel KE; Kharasch ED J Pharmacol Exp Ther; 1997 Apr; 281(1):400-11. PubMed ID: 9103523 [TBL] [Abstract][Full Text] [Related]
7. Assessment of the contributions of CYP3A4 and CYP3A5 in the metabolism of the antipsychotic agent haloperidol to its potentially neurotoxic pyridinium metabolite and effect of antidepressants on the bioactivation pathway. Kalgutkar AS; Taylor TJ; Venkatakrishnan K; Isin EM Drug Metab Dispos; 2003 Mar; 31(3):243-9. PubMed ID: 12584149 [TBL] [Abstract][Full Text] [Related]
8. Expression of cytochrome P450 3A7 in Escherichia coli: effects of 5' modification and catalytic characterization of recombinant enzyme expressed in bicistronic format with NADPH-cytochrome P450 reductase. Gillam EM; Wunsch RM; Ueng YF; Shimada T; Reilly PE; Kamataki T; Guengerich FP Arch Biochem Biophys; 1997 Oct; 346(1):81-90. PubMed ID: 9328287 [TBL] [Abstract][Full Text] [Related]
9. Involvement of multiple cytochrome P450 and UDP-glucuronosyltransferase enzymes in the in vitro metabolism of muraglitazar. Zhang D; Wang L; Chandrasena G; Ma L; Zhu M; Zhang H; Davis CD; Humphreys WG Drug Metab Dispos; 2007 Jan; 35(1):139-49. PubMed ID: 17062778 [TBL] [Abstract][Full Text] [Related]
10. Formation of a dihydroxy metabolite of phenytoin in human liver microsomes/cytosol: roles of cytochromes P450 2C9, 2C19, and 3A4. Komatsu T; Yamazaki H; Asahi S; Gillam EM; Guengerich FP; Nakajima M; Yokoi T Drug Metab Dispos; 2000 Nov; 28(11):1361-8. PubMed ID: 11038165 [TBL] [Abstract][Full Text] [Related]
11. Roles of human hepatic cytochrome P450s 2C9 and 3A4 in the metabolic activation of diclofenac. Tang W; Stearns RA; Wang RW; Chiu SH; Baillie TA Chem Res Toxicol; 1999 Feb; 12(2):192-9. PubMed ID: 10027798 [TBL] [Abstract][Full Text] [Related]
12. Phenytoin metabolism by human cytochrome P450: involvement of P450 3A and 2C forms in secondary metabolism and drug-protein adduct formation. Cuttle L; Munns AJ; Hogg NA; Scott JR; Hooper WD; Dickinson RG; Gillam EM Drug Metab Dispos; 2000 Aug; 28(8):945-50. PubMed ID: 10901705 [TBL] [Abstract][Full Text] [Related]
13. Roles of cytochromes P450 1A2 and 3A4 in the oxidation of estradiol and estrone in human liver microsomes. Yamazaki H; Shaw PM; Guengerich FP; Shimada T Chem Res Toxicol; 1998 Jun; 11(6):659-65. PubMed ID: 9625734 [TBL] [Abstract][Full Text] [Related]
14. Specificity of cDNA-expressed human and rodent cytochrome P450s in the oxidative metabolism of the potent carcinogen 7,12-dimethylbenz[a]anthracene. Shou M; Korzekwa KR; Krausz KW; Buters JT; Grogan J; Goldfarb I; Hardwick JP; Gonzalez FJ; Gelboin HV Mol Carcinog; 1996 Dec; 17(4):241-9. PubMed ID: 8989918 [TBL] [Abstract][Full Text] [Related]
15. Diazinon, chlorpyrifos and parathion are metabolised by multiple cytochromes P450 in human liver. Mutch E; Williams FM Toxicology; 2006 Jul; 224(1-2):22-32. PubMed ID: 16757081 [TBL] [Abstract][Full Text] [Related]
16. Reconstitution premixes for assays using purified recombinant human cytochrome P450, NADPH-cytochrome P450 reductase, and cytochrome b5. Shaw PM; Hosea NA; Thompson DV; Lenius JM; Guengerich FP Arch Biochem Biophys; 1997 Dec; 348(1):107-15. PubMed ID: 9390180 [TBL] [Abstract][Full Text] [Related]
17. Fentanyl metabolism by human hepatic and intestinal cytochrome P450 3A4: implications for interindividual variability in disposition, efficacy, and drug interactions. Labroo RB; Paine MF; Thummel KE; Kharasch ED Drug Metab Dispos; 1997 Sep; 25(9):1072-80. PubMed ID: 9311623 [TBL] [Abstract][Full Text] [Related]
19. CYP2D6 catalyzes tamoxifen 4-hydroxylation in human liver. Dehal SS; Kupfer D Cancer Res; 1997 Aug; 57(16):3402-6. PubMed ID: 9270005 [TBL] [Abstract][Full Text] [Related]
20. Roles of cytochrome b5 in the oxidation of testosterone and nifedipine by recombinant cytochrome P450 3A4 and by human liver microsomes. Yamazaki H; Nakano M; Imai Y; Ueng YF; Guengerich FP; Shimada T Arch Biochem Biophys; 1996 Jan; 325(2):174-82. PubMed ID: 8561495 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]